CD24 and galectin-1 expressions in gastric adenocarcinoma and clinicopathologic significance

Pathology and Oncology Research

Volumn 16, Issue 4, 2010, Pages 569-577

  Bektas, Sibel ^a   Bahadir, Burak ^a   Ucan, Bulent Hamdi ^a   Ozdamar, Sukru Oguz ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

CD24; Clinicopathologic variables; Galectin 1; Gastric adenocarcinoma; Prognosis

Indexed keywords

CD24 ANTIGEN; GALECTIN 1;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER LOCALIZATION; CANCER STAGING; CANCER SURVIVAL; CARCINOMA CELL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PERINEURIUM; PROGNOSIS; PROTEIN EXPRESSION; SEROSA; STOMACH ADENOCARCINOMA; STROMA CELL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANTIGENS, CD24; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; FEMALE; GALECTIN 1; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS;

EID: 78149410574     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9248-8     Document Type: Article

References (47)

1. DM Parkin F Bray J Ferlay, et al. 2005 Global cancer statistics, 2002 CA Cancer J Clin 55 74 108 10.3322/canjclin.55.2.74 15761078
2. Rosai J (2004) Stomach. In: Rosai J (ed) Rosai and Ackerman's surgical pathology, 9th edn. Elsevier-Mosby, New York, pp 648-684
3. YY Chou YM Jeng TT Lee, et al. 2007 Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma Ann Surg Oncol 14 2748 2758 10.1245/s10434-007-9501-x 17680316 (Pubitemid 47460653)
4. SC Lim SH Oh 2005 The role of CD24 in various human epithelial neoplasias Pathol Res Pract 201 479 486 1:CAS:528:DC%2BD2MXhtF2nt7%2FN 10.1016/j.prp.2005.05.004 16164042 (Pubitemid 41131388)
5. P Baumann N Cremers F Kroese, et al. 2005 CD24 expression causes the acquisition of multiple cellular properties associated with tumor growth and metastasis Cancer Res 65 10783 10793 1:CAS:528:DC%2BD2MXht1Kjsr7J 10.1158/0008-5472.CAN-05-0619 16322224 (Pubitemid 41715227)
6. O Li P Zheng Y Liu 2004 CD24 expression on T cells is required for optimal T cell proliferation in lymphopenic host J Exp Med 200 1083 1089 1:CAS:528:DC%2BD2cXovVensbo%3D 10.1084/jem.20040779 15477346 (Pubitemid 39431132)
7. PJ Nielsen B Lorenz AM Müller, et al. 1997 Altered erythrocytes and a leaky block in B-cell development in CD24/HSA-deficient mice Blood 89 1058 1067 1:CAS:528:DyaK2sXptFOisg%3D%3D 9028339
8. S Aigner ZM Sthoeger M Fogel, et al. 1997 CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells Blood 89 3385 3395 1:CAS:528:DyaK2sXivVylurc%3D 9129046 (Pubitemid 27229826)
9. P Athanassiadou D Grapsa M Gonidi, et al. 2009 CD24 expression has a prognostic impact in breast carcinoma Pathol Res Pract 205 524 533 10.1016/j.prp.2009.01.008 19243896
10. G Kristiansen KJ Winzer E Mayordomo, et al. 2003 CD24 expression is a new prognostic marker in breast cancer Clin Cancer Res 9 4906 4913 1:CAS:528:DC%2BD3sXosVGjtLw%3D 14581365
11. G Kristiansen C Denkert K Schlüns, et al. 2002 CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival Am J Pathol 161 1215 1221 1:CAS:528:DC%2BD38Xotlyqu7k%3D 12368195
12. HJ Lee DI Kim C Kwak, et al. 2008 Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance Urology 72 603 607 10.1016/j.urology.2008.01.061 18384848
13. G Kristiansen C Pilarsky J Pervan, et al. 2004 CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer Prostate 58 183 192 10.1002/pros.10324 14716744 (Pubitemid 38160906)
14. A Sano H Kato S Sakurai, et al. 2009 CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma Ann Surg Oncol 16 506 514 10.1245/s10434-008-0252-0 19050962
15. G Kristiansen K Schlüns Y Yongwei, et al. 2003 CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients Br J Cancer 88 231 236 1:STN:280:DC%2BD3s%2FpslSitg%3D%3D 10.1038/sj.bjc.6600702 12610508 (Pubitemid 36255841)
16. V Georgiadis HJ Stewart HJ Pollard, et al. 2007 Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration Dev Dyn 236 1014 1024 1:CAS:528:DC%2BD2sXltlWnsb8%3D 10.1002/dvdy.21123 17366633 (Pubitemid 46641342)
17. DK Hsu FT Liu 2004 Regulation of cellular homeostasis by galectins Glycoconj J 19 507 515 10.1023/B:GLYC.0000014080.95829.52 14758074
18. A Hittelet H Legendre N Nagy, et al. 2003 Upregulation of galectins-1 and -3 in human colon cancer and their role in regulating cell migration Int J Cancer 103 370 379 1:CAS:528:DC%2BD3sXht1yisw%3D%3D 10.1002/ijc.10843 12471620 (Pubitemid 36076430)
19. M Sakaguchi Y Imaizumi H Okano 2007 Expression and function of galectin-1 in adult neural stem cells Cell Mol Life Sci 64 1254 1258 1:CAS:528: DC%2BD2sXlvFOju7c%3D 10.1007/s00018-007-6476-5 17364145 (Pubitemid 46791052)
20. A Satelli PS Rao PK Gupta, et al. 2008 Varied expression and localization of multiple galectins in different cancer cell lines Oncol Rep 19 587 594 1:CAS:528:DC%2BD1cXjs1emu7Y%3D 18288388
21. VL Thijssen S Hulsmans AW Griffioen 2008 The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells Am J Pathol 172 545 553 1:CAS:528:DC%2BD1cXis1aisL0%3D 10.2353/ajpath.2008.070938 18202194 (Pubitemid 351282039)
22. EJ Jung HG Moon BI Cho, et al. 2007 Galectin-1 expression in cancer-associated stromal cells correlates tumor invasiveness and tumor progression in breast cancer Int J Cancer 120 2331 2338 1:CAS:528: DC%2BD2sXksFSktLc%3D 10.1002/ijc.22434 17304502 (Pubitemid 46642118)
23. N Clausse F van den Brûle D Waltregny, et al. 1999 Galectin-1 expression in prostate tumor-associated capillary endothelial cells is increased by prostate carcinoma cells and modulates heterotypic cell-cell adhesion Angiogenesis 3 317 325 1:CAS:528:DC%2BD3MXps1CitA%3D%3D 10.1023/A:1026584523789 14517411
24. N Nagy H Legendre O Engels, et al. 2003 Refined prognostic evaluation in colon carcinoma using immunohistochemical galectin fingerprinting Cancer 97 1849 1858 10.1002/cncr.11268 12673710 (Pubitemid 36397258)
25. G Kristiansen M Sammar P Altevogt 2004 Tumour biological aspects of CD24, a mucin-like adhesion molecule J Mol Histol 35 255 262 1:CAS:528: DC%2BD2cXltVWqs7c%3D 10.1023/B:HIJO.0000032357.16261.c5 15339045 (Pubitemid 40585311)
26. SC Lim 2005 CD24 and human carcinoma: tumor biological aspects Biomed Pharmacother 59 S351 S354 1:CAS:528:DC%2BD28Xpt1Cmuw%3D%3D 10.1016/S0753- 3322(05)80076-9 16507407
27. F van den Brûle S Califice V Castronovo 2004 Expression of galectins in cancer: a critical review Glycoconj J 19 537 542 10.1023/B:GLYC.0000014083.48508.6a 14758077
28. I Camby M Le Mercier F Lefranc, et al. 2006 Galectin-1: a small protein with major functions Glycobiology 16 137R 157R 1:CAS:528:DC%2BD28XhtVOmurfI 10.1093/glycob/cwl025 16840800 (Pubitemid 44530693)
29. M Fogel J Friederichs Y Zeller, et al. 1999 CD24 is a marker for human breast carcinoma Cancer Lett 143 87 94 1:CAS:528:DyaK1MXltlKju70%3D 10.1016/S0304-3835(99)00195-0 10465342 (Pubitemid 29327194)
30. S Bircan N Kapucuoglu S Baspinar, et al. 2006 CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study Pathol Res Pract 202 569 576 1:CAS:528:DC%2BD28XpvVCltrw%3D 10.1016/j.prp.2006.05.004 16828238 (Pubitemid 44057770)
31. W Weichert C Denkert M Burkhardt, et al. 2005 Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival Clin Cancer Res 11 6574 6581 1:CAS:528:DC%2BD2MXhtVShsb%2FK 10.1158/1078-0432. CCR-05-0606 16166435 (Pubitemid 41338997)
32. E Sagiv N Arber 2008 The novel oncogene CD24 and its arising role in the carcinogenesis of the GI tract: from research to therapy Expert Rev Gastroenterol Hepatol 2 125 133 1:CAS:528:DC%2BD1cXjtFOisbg%3D 10.1586/17474124.2.1.125 19072375
33. B Nagy A Szendroi I Romics 2009 Overexpression of CD24, c-myc and phospholipase 2A in prostate cancer tissue samples obtained by needle biopsy Pathol Oncol Res 15 279 283 1:CAS:528:DC%2BD1MXlvV2hu74%3D 10.1007/s12253-008- 9077-1 18752058
34. LR Huang HC Hsu 1995 Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation Cancer Res 55 4717 4721 1:CAS:528:DyaK2MXoslWmtr4%3D 7553654
35. KH Kim JS Choi JM Kim, et al. 2009 Enhanced CD24 expression in endometrial carcinoma and its expression pattern in normal and hyperplastic endometrium Histol Histopathol 24 309 316 19130400
36. JB Kim E Ko W Han, et al. 2008 CD24 cross-linking induces apoptosis in, and inhibits migration of, MCF-7 breast cancer cells BMC Cancer 24 118 1:CAS:528:DC%2BD1cXhtFKjtQ%3D%3D 10.1186/1471-2407-8-118 (Pubitemid 351715877)
37. S Agrawal BW Kuvshinoff T Khoury, et al. 2007 CD24 expression is an independent prognostic marker in cholangiocarcinoma J Gastrointest Surg 11 445 451 10.1007/s11605-007-0091-5 17436128
38. L Chiariotti MT Berlingieri C Battaglia, et al. 1995 Expression of galectin-1 in normal human tyroid gland and in differentiated and poorly differentiated tyroid tumors Int J Cancer 64 171 175 1:CAS:528: DyaK2MXnt1Cit78%3D 10.1002/ijc.2910640305 7622305
39. F van den Brule S Califice F Garnier, et al. 2003 Galectin-1 accumulation in the ovary carcinoma peritumoral stroma is induced by ovary carcinoma cells and affects both cancer cell proliferation and adhesion to laminin-1 and fibronectin Lab Invest 83 377 386 12649338
40. T Shimonishi K Miyazaki N Kano, et al. 2001 Expression of endogenous galectin-1 and galectin-3 in intrahepatic cholangiocarcinoma Hum Pathol 32 302 310 1:CAS:528:DC%2BD3MXjtVSgsLc%3D 10.1053/hupa.2001.22767 11274640 (Pubitemid 32246805)
41. PO Berberat H Friess L Wang, et al. 2001 Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer J Histochem Cytochem 49 539 549 1:CAS:528:DC%2BD3MXivFKgtrk%3D 11259457
42. L Cindolo G Benvenuto G Salvatore, et al. 1999 Galectin-1 and galectin-3 expression in human bladder transitional-cell carcinoma Int J Cancer 84 39 43 1:CAS:528:DyaK1MXht1Cqt7o%3D 10.1002/(SICI)1097-0215(19990219)84:1<39::AID- IJC8>3.0.CO;2-E 9988230 (Pubitemid 29059106)
43. DN Cooper SH Barondes 1990 Evidence for export of a muscle lectin from cytosol to extracellular matrix and for a novel secretory mechanism J Cell Biol 110 1681 1691 1:CAS:528:DyaK3cXhvFGkt7c%3D 10.1083/jcb.110.5.1681 2335567 (Pubitemid 20169506)
44. F van den Brule D Waltregny V Castronovo 2001 Increased expression of galectin-1 in carcinoma-associated stroma predicts poor outcome in prostate carcinomapatients J Pathol 193 80 87 10.1002/1096-9896(2000)9999:9999<::AID- PATH730>3.0.CO;2-2 11169519 (Pubitemid 32051116)
45. XL Zhu L Liang YQ Ding 2007 Galectin-1 expression in human colorectal carcinoma and its clinical significance Nan Fang Yi Ke Da Xue Xue Bao 27 1331 1334 1:CAS:528:DC%2BD2sXhtF2isLrM 17884770
46. QT Le G Shi H Cao, et al. 2005 Galectin-1: a link between tumor hypoxia and tumor immune privilege J Clin Oncol 23 8932 8941 1:CAS:528: DC%2BD28XktVCgtQ%3D%3D 10.1200/JCO.2005.02.0206 16219933 (Pubitemid 46211478)
47. S Rorive N Belot C Decaestecker, et al. 2001 Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma Glia 33 241 255 1:STN:280: DC%2BD3M3lvFOgsA%3D%3D 10.1002/1098-1136(200103)33:3<241::AID-GLIA1023>3. 0.CO;2-1 11241742 (Pubitemid 32219133)